ASX/CMB (ASX/CMB)

Australian Securities Exchange: ASX/CMB · AUD

A$0.40

-0.02 (-4.8%)· Recorded snapshot

Market cap	11.8M
Revenue (ttm)	1.2M
Net income (ttm)	-4.1M
EPS (ttm)	-A$0.17
Shares out	29.4M
Volume	1,300
Beta	-0.52

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1.2M
Net income (ttm): -4.1M
EPS (ttm): -A$0.17
Market cap: 11.8M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-30 13:30 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-194.4

P25 n/aP50 n/aP75 n/a

ROIC-97.3

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All ASX/CMB indicators

Market & fundamental data

Available fields

150

Groups with data

Currency

AUD

Showing 150 of 150 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	AUD
Country	Australia
Country code	AU
Earnings date	2026-09-04
Enterprise value	AUD 10.8M
Exchange	Australian Securities Exchange
Financial currency	AUD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	June
Founded	2013
Industry	Biotechnology
Is primary listing	Yes
ISIN number	AU000000RGS6
Last refreshed	2026-10-30
Last stock split date	2024-07-04
Last stock split type	Reverse
Market cap	AUD 11.8M
Price	AUD 0.40
Price currency	AUD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-30
Symbol	asx/CMB
Website	https://www.cambium.bio

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-42.91%
EV/Sales	8.82x
FCF / EV yield	-26%
FCF yield	-23.87%
Industry forward P/E	28.82x
P/B ratio	4.95x
P/S ratio	9.61x
Sector forward P/E	34.06x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	84.47%
Operating margin	-307.87%
Pretax margin	-334.2%
ROA	-66.82%
ROCE	-158.61%
ROE	-194.37%
ROIC	-97.31%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	4
Gross profit growth	80.34%
Gross profit growth (Q)	5,452.54%
Net income growth years	0
Revenue growth	58.17%
Revenue growth (Q)	446.55%
Revenue growth (QoQ)	25.26%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	AUD -2,638
Depreciation and amortization	AUD 2,638
EBIT	AUD -3.8M
EBITDA	AUD -3.8M
EPS	AUD -0.17
FCF per share	AUD -0.10
Financing cash flow	AUD 4.2M
Free cash flow	AUD -2.8M
Gross profit	AUD 1M
Investing cash flow	AUD -322,638
Net borrowing	AUD -318,654
Net cash flow	AUD 949,762
Net income	AUD -4.1M
Operating income	AUD -3.8M
Revenue	AUD 1.2M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-16.72
Book value per share	AUD 0.09
Debt / equity	0.06
Interest coverage	-17,151.82
Long-term assets	AUD 2.5M
Long-term liabilities	AUD 0
Net cash (debt)	AUD 966,363
Net cash / market cap	8.21%
Net debt / equity	-0.41
Piotroski F-Score	4
Shareholders' equity	AUD 2.4M
Tangible book value	AUD -70,436
Tangible book value per share	AUD -0.00
Total assets	AUD 3.8M
Total cash	AUD 1.1M
Total debt	AUD 149,804
Total liabilities	AUD 1.4M
WACC	1.35%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.35
Current assets	AUD 1.3M
Current liabilities	AUD 1.4M
Current ratio	0.95
Net working capital	AUD -1M
Quick ratio	0.93
Working capital	AUD -72,986
Working capital turnover	-2.73

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-30.54%
Shareholder yield	-30.54%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	AUD 0.47
1D price change	-4.76%
1M price change	-20%
1M total return	-20%
1W price change	-4.76%
1W total return	-4.76%
1Y price change	-16.67%
1Y return CAGR	-16.68%
1Y total return	-16.67%
20-day SMA	AUD 0.47
200-day SMA	AUD 0.45
3M price change	-6.98%
3M total return	-6.98%
50-day SMA	AUD 0.44
50-day SMA vs 200-day SMA	50under200
52-week high	AUD 0.60
52-week high date	2026-02-03
52-week low	AUD 0.34
52-week low date	2026-08-17
6M price change	-11.11%
6M total return	-11.11%
All-time high	AUD 1.60
All-time high date	2024-04-05
All-time low	AUD 0.19
All-time low date	2025-05-08
Average true range (ATR)	AUD 0.02
Average volume	4.9K
Beta (1Y)	0.05
Beta (2Y)	-0.33
Beta (5Y)	-0.52
Change from 52-week high	-33.33%
Change from 52-week low	17.65%
Change from all-time high	-75%
Change from all-time low	110.53%
Change from open	0%
Day's gap	-4.76%
Dollar volume	AUD 520
High price	AUD 0.40
Low price	AUD 0.40
Monthly RSI	42.3
Open price	AUD 0.40
Previous close	AUD 0.42
Price vs 150-day SMA	-14.55%
Price vs 20-day SMA	-15.7%
Price vs 200-day SMA	-12.05%
Price vs 50-day SMA	-9.62%
Relative volume	0.27
RSI	39.68
Sharpe ratio	0.58
Sortino ratio	1.17
Volume	1.3K
Weekly RSI	44.27
YTD price change	-14.89%
YTD total return	-14.89%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3.7M
Shares change (QoQ)	22.01%
Shares change (YoY)	30.54%
Shares held by insiders	34.89%
Shares outstanding	29.4M

Deeper analysis on ASX/CMB

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ASX/CMB report

Is a complete ASX/CMB research report available?

No complete published report is available for asx/CMB (ASX/CMB) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

ASX/CMB (ASX/CMB)

Price

Financial snapshot

Fair-value bridge

Latest news · ASX/CMB

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ASX/CMB indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ASX/CMB

Frequently asked questions